European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

JPIAMR- ANTIMICROBIAL TRANSMISSION INTERVENTIONS

Descrizione del progetto

DE EN ES FR IT PL

Lottare contro la minaccia per la salute della resistenza agli antimicrobici

La resistenza agli antimicrobici è un serio problema a livello globale che minaccia la prevenzione e il trattamento efficaci di un’ampia gamma di infezioni. Nell’affrontare ciò, il progetto JPIAMR-ACTION, finanziato dall’UE nell’ambito dell’azione ERA-NET Cofund, sosterrà la ricerca e l’innovazione per sviluppare strategie e metodologie che diminuiranno la trasmissione e la diffusione della resistenza agli antimicrobici all’interno di uno spettro «One Health» completo. L’invito a presentare proposte co-finanziato JPIAMR-ACTION, fondamentale per il suo conseguimento, si propone di portare alla luce l’impatto di interventi sullo sviluppo e la trasmissione della resistenza agli antibiotici, tra gli altri obiettivi. Questo invito, assieme ad altre attività, fornirà nuovi approcci e rafforzerà le azioni esistenti, mirando a interventi che porranno fine alla resistenza agli antimicrobici negli esseri umani, negli animali e nell’ambiente lungo il suo percorso.

Obiettivo

In the past 90 years since their discovery, antibiotics have saved millions of lives from bacterial diseases. However, emerging resistance to antimicrobials now threatens many advances achieved in modern medicine. AMR is a critical global health issue tightly linked with the One Health concept, which recognises that human and animal health are inextricably linked, and that diseases are transmitted from humans to animals and vice versa. One Health also encompasses the environment as another link between humans and animals and a potential source and reservoir of AMR. Antimicrobial resistance is a growing global health concern and threatens the future treatment and health of humans and animals. In addition, AMR limits our ability to achieve several of the UN Sustainable Development Goals (SDGs). The global challenge to address AMR goes beyond the production of new antibiotics and therapies. Reducing demand for new antibiotics through public awareness, infection prevention and control, prudent and rational use of antibiotics for humans and animals, as well as effective diagnosis and surveillance of antibiotic-resistant infections and monitoring antibiotic use, are crucial when dealing with this problem globally. The transmission and spread of AMR in and between One Health compartments is complex, which emphasises the need for comprehensive interventions to reverse the trend of increasing human and animal infections resistant to treatment. The ERA-NET Cofund JPIAMR-ACTION will tackle this central challenge by supporting research and innovation for the development and testing of strategies and methodologies to reduce the transmission and spread of AMR within a full One Health spectrum. The JPIAMR-ACTION co-funded call and other activities will be instrumental in producing new innovative approaches, and advancing existing actions towards the development of new and improved interventions to inhibit or limit the development of AMR in humans, animals and the environment.

Campo scientifico

Parole chiave

Programma(i)

Argomento(i)

Invito a presentare proposte

H2020-SC1-BHC-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-SC1-2020-Single-Stage-RTD

Meccanismo di finanziamento

ERA-NET-Cofund - ERA-NET Cofund

Coordinatore

VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL
Contribution nette de l'UE
€ 1 049 812,50
Indirizzo
BOX 1035
101 38 Stockholm
Svezia

Mostra sulla mappa
Regione
Östra Sverige Stockholm Stockholms län
Tipo di attività
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Collegamenti
Costo totale
€ 3 181 250,00

Partecipanti (25)

Condividi questa pagina

Scarica

Ultimo aggiornamento: 24 Gennaio 2024

Il mio booklet

Permalink: https://cordis.europa.eu/project/id/963864/it

European Union, 2024